Cargando…
Au-CGKRK Nanoconjugates for Combating Cancer through T-Cell-Driven Therapeutic RNA Interference
[Image: see text] Numerous prior studies on fighting cancer have been based on using inhibitors of JAK-STAT pathway (signal transducer and activator of transcription 3 (STAT3) inhibitor in particular), a signaling pathway responsible for progression of many types of cancer cells. However, recent stu...
Autores principales: | Gulla, Suresh Kumar, Kotcherlakota, Rajesh, Nimushakavi, Sahithi, Nimmu, Narendra Varma, Khalid, Sara, Patra, Chitta Ranjan, Chaudhuri, Arabinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644890/ https://www.ncbi.nlm.nih.gov/pubmed/31458997 http://dx.doi.org/10.1021/acsomega.8b01051 |
Ejemplares similares
-
Potential Theranostics Application of Bio-Synthesized Silver Nanoparticles (4-in-1 System)
por: Mukherjee, Sudip, et al.
Publicado: (2014) -
Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates
por: Sharma, Meenakshi, et al.
Publicado: (2017) -
Application of nickel chitosan nanoconjugate as an antifungal agent for combating Fusarium rot of wheat
por: Chouhan, Divya, et al.
Publicado: (2022) -
Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles
por: Lv, Lingyan, et al.
Publicado: (2020) -
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
por: Garu, Arup, et al.
Publicado: (2016)